Jounce Therapeutics, Inc.

RHUMBLINE ADVISERS

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/11/2023

Shares

63,356

Value ($000)

117

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/11/2023	117	0.0%	63,356	3/31/2023
2022 Q4	2/14/2023	70	0.0%	63,066	12/31/2022
2022 Q3	11/10/2022	148	0.0%	63,129	9/30/2022
2022 Q2	8/11/2022	174	0.0%	57,441	6/30/2022
2022 Q1	5/12/2022	292	0.0%	43,035	3/31/2022
2021 Q4	2/10/2022	373	0.0%	44,718	12/31/2021
2021 Q3	11/12/2021	316	0.0%	42,573	9/30/2021
2021 Q2	8/5/2021	282	0.0%	41,406	6/30/2021
2021 Q1	5/6/2021	286	0.0%	27,847	3/31/2021
2020 Q4	2/10/2021	202	0.0%	28,897	12/31/2020
2020 Q3	11/12/2020	206	0.0%	25,262	9/30/2020
2020 Q2	8/13/2020	201	0.0%	29,069	6/30/2020
2020 Q1	5/6/2020	132	0.0%	27,735	3/31/2020
2019 Q4	2/5/2020	221	0.0%	25,305	12/31/2019